| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT03345498 |
| P17 | country | India | Q668 |
| P582 | end time | 2018-06-30 | |
| P1050 | medical condition | hepatitis B | Q6853 |
| hepatitis | Q131742 | ||
| liver cirrhosis | Q147778 | ||
| P2899 | minimum age | 19 | |
| P1132 | number of participants | 30 | |
| P6153 | research site | Sanjay Gandhi Post Graduate Institute of Medical Sciences | Q7418428 |
| P580 | start time | 2017-01-01 | |
| P8363 | study type | observational study | Q818574 |
| P1476 | title | Study to Compare Virological Response to 0.5 mg Daily Versus 1.0 mg Daily Oral Doses of Entecavir in Chronic Hepatitis B Virus Infection Related Decompensated Cirrhosis |
Search more.